Replies to post #222774 on NorthWest Biotherapeutics Inc (NWBO)

[sentiment_stocks]

After top line, will all the spinning wheels be thrown out with the trash and burned?

[maverick_1]

TOP 20 GBM INSTITUTIONS
Of the 31 unique institutions that make up these lists, 22 are US-based organizations, eight from Europe, and one from Canada. There are definite research clusters visible with these institutions: in the US, there are clusters in the New England and Mid-Atlantic regions (Harvard, Dana Farber, Massachusetts General Hospital, Brigham & Women's Hospital, Memorial Sloan Kettering, the universities of Pennsylvania and Pittsburgh, Johns Hopkins, and the National Cancer Institute), California (three Universities of California—San Diego, San Francisco, and Los Angeles), Texas (Baylor, the University of Texas MD Anderson Cancer Center, and the University of Texas Health Science Center San Antonio).

In Europe, Germany (German Cancer Research Center, and the universities of Dusseldorf, Heidelberg, Tubingen, and Regensburg), and Switzerland (University of Zurich, University of Lausanne) show this trend.


#7 JOHNS HOPKINS UNIV
#9 UNIV CALIF LOS ANGELES

http://archive.sciencewatch.com/ana/st/glio/institutions/

John Hopkins was NOT involved in DC VAX L Clinicals:
https://clinicaltrials.gov/ct2/show/study/NCT00045968?show_locs=Y#locn

FWIW: Within the Top Ten GBM institutions being positively disposed towards DC VAX L PH3 results as of this date are UCLA and John Hopkins Univ.

Also Heidelberg Univ in Germany was a GBM clinical site.
Univ of Penna was a GBM clinical site.
And one of the two Canadian DC VAX L chosen sites maybe the leading GBM institution in Canada

NOTE: USCF is #2: Instigator of a key lawsuit (was DISMISSED!)against NWBO

DIFFERENT STROKES FOR DIFFERENT FOLKS